MICROBIOLOGÍA, ENFERMEDADES INFECCIOSAS, ANTIMICROBIANOS Y TERAPIA GÉNICA
Hospital Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Carlos III (6)
2014
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
2012
-
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial
Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968
2011
-
Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/Hepatitis C virus-coinfected patients treated for chronic hepatitis C
Clinical Infectious Diseases, Vol. 53, Núm. 12, pp. 1291-1295
2010
-
Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C
AIDS Research and Human Retroviruses, Vol. 26, Núm. 4, pp. 419-424
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
-
Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C
AIDS, Vol. 22, Núm. 1, pp. 15-21